• ATS Medical (Minneapolis) reported the completion of its $22 million all-cash acquisition of the surgical cryoablation business of CryoCath Technologies (Montreal). The deal was first reported in late June. With milestone payments, the agreement could increase in value to reach a total of $30 million. The assets being acquired include the SurgiFrost, FrostByte, and SurgiFrost XL family of products for which ATS Medical has been CryoCath’s exclusive agent in the U.S. and distributor in certain international markets since November 2004. CryoCath said in a statement that the sale of the surgical business “marks a significant milestone in our strategy to transition CryoCath into a focused and fast growing electrophysiology cryoablation company,” ATS Medical is a maker of cardiac surgery products including heart valves.

• Boston Scientific (Natick, Massachusetts) reported its intention to explore the sale of its fluid management business as part of the company’s ongoing review of its portfolio of assets. The fluid management business, formerly North American Medical Instruments Cor, produces products used to manage fluid and measure pressure during angiography and angioplasty procedures. A sale would be expected to include the company’s facilities in Glens Falls, New York, and Tullamore, Ireland. “As we have previously announced, we are conducting a comprehensive review of our non-strategic assets in an effort to focus resources on our core businesses and improve our financial strength,” said Paul LaViolette, company COO. “This is a very strong business with market leadership, and we believe it has tremendous potential with the focused attention and resources of external ownership. We are in the early stages of discussions with several potential acquirers, and we expect the process to take a number of months.”

• CardioTech International (Wilmington, Massachusetts), a developer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, reported that its agreement to sell its Gish Biomedical (Rancho Santa Margarita, California) subsidiary in a stock transaction to Medos Medizintechnik (Stolberg, Germany) for about $7.5 million has closed. After estimated transaction costs of $500,000 and escrow funding, CardioTech expects to realize about $6 million in cash from the sale. The company said it will use the net cash proceeds to fund its growth initiatives focused on selling complex medical devices and licensing and selling its ChronoFlex family of specially formulated polymers to medical device manufacturers. In February, CardioTech reported its plans to sell Gish with the company saying at the time that Gish was not a fit with CardioTech’s strategic direction. CardioTech acquired Gish in March 2003.

• Haemonetics (Braintree, Massachusetts), a global developer of blood management solutions, reported that it has acquired Infonale (West Chester, Pennsylvania) for $1.3 million in cash plus contingent consideration based upon future operating performance. Infonale is a developer of IT software and consulting services for optimizing hospital blood use and management. Infonale provides hospitals with consulting services, backed by IT software, that track blood use data, including total charges by physician, patient length of stay comparisons, and diagnosis-related group (DRG) care patterns. The Infonale systems have shown that hospitals can improve patient outcomes and save costs by steering blood management policies and practices to evidence-based best practices. Haemonetics estimates this market at greater than $35 million. Infonale’s personnel and operations will remain in the Philadelphia area. Haemonetics makes automated blood processing systems.

• Pediatrix Medical Group (Fort Lauderdale, Florida) reported that it has completed the acquisition of a pediatric cardiology physician group practice based in San Antonio which provides physician services to patients in communities throughout south central Texas. he five pediatric cardiologists practicing as Pediatric Cardiology Associates are now part of Pediatrix’s national group practice, a provider of newborn, maternal-fetal and pediatric subspecialty physician services. Pediatrix paid an undisclosed amount of cash for the San Antonio practice and expects that this acquisition will be immediately accretive.

• Teleflex (Limerick, Pennsylvania) continued its recent expansion into medical technology with the $2 billion all-cash acquisition of Arrow International (Reading, Pennsylvania), a manufacturer of disposable catheters and related products for critical and cardiac care would provide a cash payment of $45.50 a share for each outstanding share of Arrow, a premium of 20% over Arrow’s closing share price on July 20, 2007. Teleflex is a supplier of disposable medical products, surgical instruments and medical devices in three main areas: respiratory care; urology instruments; and specialty sutures used in surgery. It markets its products under the HudsonRCI and R sch brand names, and surgical instruments and medical devices under the Beere, Deknatel, KMedic, Pilling, Taut and Weck brands.